REPLACE and the role of riociguat in pulmonary arterial hypertension therapy

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	546-547
Number of pages	2
Journal	The Lancet Respiratory Medicine
Volume	9
Issue number	6
DOIs	https://doi.org/10.1016/S2213-2600(20)30567-1
State	Published - Jun 2021

ASJC Scopus subject areas

@article{562ebd34adc147e7b33918c0c33a50b9,

title = "REPLACE and the role of riociguat in pulmonary arterial hypertension therapy",

author = "Frantz, {Robert P.}",

year = "2021",

month = jun,

doi = "10.1016/S2213-2600(20)30567-1",

language = "English (US)",

volume = "9",

pages = "546--547",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "6",

}

TY - JOUR

T1 - REPLACE and the role of riociguat in pulmonary arterial hypertension therapy

AU - Frantz, Robert P.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85104083709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85104083709&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(20)30567-1

DO - 10.1016/S2213-2600(20)30567-1

M3 - Comment/debate

C2 - 33773119

AN - SCOPUS:85104083709

SN - 2213-2600

VL - 9

SP - 546

EP - 547

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 6

ER -